268 related articles for article (PubMed ID: 29403325)
1. TAFRO syndrome: current perspectives.
Sakashita K; Murata K; Takamori M
J Blood Med; 2018; 9():15-23. PubMed ID: 29403325
[TBL] [Abstract][Full Text] [Related]
2. Multicentric Castleman's disease in India - Does EBV rather than HHV8 play a role?
Bhanvadia V; Shet T; Rao V; Epari S; Gujral S; Jain H; Bagal B; Sengar M
Indian J Pathol Microbiol; 2021; 64(2):302-309. PubMed ID: 33851624
[TBL] [Abstract][Full Text] [Related]
3. A Patient With Human Herpesvirus 8-Positive Multicentric Castleman's Disease Who Met Criteria for TAFRO Syndrome: Controversy in Practice?
Fuentes-Lacouture MC; Gomez CC; Romero M; Borda A; Norena I; Naranjo JA
J Med Cases; 2020 Aug; 11(8):253-255. PubMed ID: 34434406
[TBL] [Abstract][Full Text] [Related]
4. Human herpesvirus 8 DNA in HIV-negative Japanese patients with multicentric Castleman's disease and related diseases.
Tohda S; Murakami N; Nara N
Int J Mol Med; 2001 Nov; 8(5):549-51. PubMed ID: 11605026
[TBL] [Abstract][Full Text] [Related]
5. Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.
Iwaki N; Sato Y; Takata K; Kondo E; Ohno K; Takeuchi M; Orita Y; Nakao S; Yoshino T
J Clin Exp Hematop; 2013; 53(1):87-93. PubMed ID: 23801139
[TBL] [Abstract][Full Text] [Related]
6. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
[TBL] [Abstract][Full Text] [Related]
7. [Pseudo-adult Still's disease, anasarca, thrombotic thrombocytopenic purpura and dysautonomia: An atypical presentation of multicentric Castleman's disease. Discussion of TAFRO syndrome].
Jouvray M; Terriou L; Meignin V; Bouchindhomme B; Jourdain M; Lambert M; Lefevre G; Hachulla E; Hatron PY; Galicier L; Launay D
Rev Med Interne; 2016 Jan; 37(1):53-7. PubMed ID: 26411598
[TBL] [Abstract][Full Text] [Related]
8. TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease?
Takai K
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540266
[TBL] [Abstract][Full Text] [Related]
9. An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapy.
Sakashita K; Murata K; Inagaki Y; Oota S; Takamori M
Respirol Case Rep; 2016 Sep; 4(5):e00173. PubMed ID: 27516889
[TBL] [Abstract][Full Text] [Related]
10. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y
J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.
Tedesco S; Postacchini L; Manfredi L; Goteri G; Luchetti MM; Festa A; Gabrielli A; Pomponio G
Exp Hematol Oncol; 2015; 4(1):3. PubMed ID: 25671135
[TBL] [Abstract][Full Text] [Related]
12. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
[TBL] [Abstract][Full Text] [Related]
13. HHV8-Positive Multicentric Castleman's Disease and Thrombotic Thrombocytopenic Purpura among HIV-Positive Patients.
Pasquer R; Dieudonné Y; Decours P; Hinschberger O; Nicolae A; Martinot M
Eur J Case Rep Intern Med; 2024; 11(3):004361. PubMed ID: 38455701
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.
Iwaki N; Fajgenbaum DC; Nabel CS; Gion Y; Kondo E; Kawano M; Masunari T; Yoshida I; Moro H; Nikkuni K; Takai K; Matsue K; Kurosawa M; Hagihara M; Saito A; Okamoto M; Yokota K; Hiraiwa S; Nakamura N; Nakao S; Yoshino T; Sato Y
Am J Hematol; 2016 Feb; 91(2):220-6. PubMed ID: 26805758
[TBL] [Abstract][Full Text] [Related]
15. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
Kubokawa I; Yachie A; Hayakawa A; Hirase S; Yamamoto N; Mori T; Yanai T; Takeshima Y; Kyo E; Kageyama G; Nagai H; Uehara K; Kojima M; Iijima K
BMC Pediatr; 2014 Jun; 14():139. PubMed ID: 24890946
[TBL] [Abstract][Full Text] [Related]
16. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
[TBL] [Abstract][Full Text] [Related]
17. A case of TAFRO syndrome with a large mediastinal mass treated with debulking surgery.
Nagano M; Matsumoto J
Surg Case Rep; 2016 Dec; 2(1):61. PubMed ID: 27316721
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and morphological features of different types of Castleman's disease].
Melikyan AL; Egorova EK; Kovrigina АМ; Subortseva IN; Gilyazitdinova EA; Karagyulyan SR; Silaev MA; Gemdzhian EG; Savchenko VG
Ter Arkh; 2015; 87(7):64-71. PubMed ID: 26390727
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic multicentric Castleman's disease: a systematic literature review.
Liu AY; Nabel CS; Finkelman BS; Ruth JR; Kurzrock R; van Rhee F; Krymskaya VP; Kelleher D; Rubenstein AH; Fajgenbaum DC
Lancet Haematol; 2016 Apr; 3(4):e163-75. PubMed ID: 27063975
[TBL] [Abstract][Full Text] [Related]
20. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y
Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
